Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis
Authors:
- Consuelo Salas-LabadíaCSConsuelo Salas-Labadía
- Esther LiebermanELEsther Lieberman
- Roberto Cruz-AlcívarRCRoberto Cruz-Alcívar
- Pilar Navarrete-MenesesPNPilar Navarrete-Meneses
- Samuel GómezSGSamuel Gómez
- Consuelo Cantú-ReynaCCConsuelo Cantú-Reyna
- Karin BuitingKBKarin Buiting
- Carola Durán-McKinsterCDCarola Durán-McKinster
- Patricia Pérez-VeraPPPatricia Pérez-Vera
Open Access
- 25 September 2014
- journal article
- case report
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 7 (1) , 65
Abstract
Trisomy 14 mosaicism is a rare chromosomal abnormality. It is associated with multiple congenital anomalies. We report a 15 year-old female with an unusual karyotype with three cell lines: 47,XX,+mar/47,XX,+14/46,XX. At six months old she had short stature, cleft palate, hyperpigmented linear spots in arms and legs and developmental delay. At present, she has mild facial dysmorphism and moderate mental retardation. Cytogenetic analysis was performed in peripheral blood lymphocytes and in the light and dark skin following standard methods. DNAarray - Oligo 180 k was carried out using Agilent Technologies and FISH analysis was accomplished using DNA BACs probes to confirm the result obtained by DNAarray. Methylation-Specific PCR (MS-PCR) of the MEG3 promoter and microsatellite analysis were performed. Microarray analysis confirmed partial trisomy 14 mosaicism; the marker chromosome was found to be from chromosome 14, the result was confirmed with FISH. Methylation (14q32.3) and microsatellite (14q11-14q32.33) analysis were carried out and UPD was discarded. The global result was: mos 47,XX,+del(14)(q11.2)[45]/47,XX,+14[10]/46,XX[45]. This is a unique case because of the coexistence of two abnormal cell lines, including one with +14 and another with +del(14)(q11.2). To our knowledge, only three patients have been reported with trisomy 14 and another abnormal cell line. The array analysis identified the marker chromosome and characterized the breakpoint. The del(14)(q11.2) does not seem to be related to any particular phenotypic characteristic of the patient; the clinical features of our patient observed until now, can be attributed to trisomy 14 mosaicism. Nevertheless, we cannot discard the manifestation of new symptoms related to her karyotype in the future.Keywords
This publication has 19 references indexed in Scilit:
- Unusual cytogenetic mosaicism involving chromosome 14 abnormalities in a child with an MR/MCA syndrome and abnormal pigmentationClinical Genetics, 2008
- Is trisomy 14 mosaic a clinically recognizable syndrome?—Case report and reviewAmerican Journal of Medical Genetics Part A, 2008
- Low‐level mosaicism of trisomy 14: Phenotypic and molecular characterizationAmerican Journal of Medical Genetics Part A, 2008
- First case reported of Turner syndrome and trisomy 14 chromosomal mosaicism in a patientClinical Dysmorphology, 2008
- Mosaic Trisomy r(14) Associated With Epilepsy and Mental RetardationJournal of Child Neurology, 2007
- Is there a higher incidence of maternal uniparental disomy 14 [upd(14)mat]? Detection of 10 new patients by methylation‐specific PCRAmerican Journal of Medical Genetics Part A, 2006
- Small supernumerary marker chromosomes (sSMC) in humansCytogenetic and Genome Research, 2004
- A Strategy to Detect Chromosomal Abnormalities in Children With Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 2004
- Trisomy 14 Mosaicism: A Case Report and Review of the LiteratureJournal of Perinatology, 2004
- Supernumerary marker chromosomes (SMC) and uniparental disomy (UPD): coincidence or consequence?Journal of Medical Genetics, 2002